Situation Report - 25 Indonesia Situation Report - 7 Indonesia

CoronavirusINDONESIA Situation Disease Report 2019 19 (COVID -19) WorldWorld Health Health CoronavirusCoronavirus Disease Disease 2019 2019 (COVID (COVID-19) -19) Internal for SEARO OrganizationOrganization

16 SeptemberData as of 072020 May 2020

HIGHLIGHTS • As of 16 September, the Government of Indonesia announced 228 993 (3 963 new) confirmed cases of COVID-19, 9 100 (135 new) deaths and 164 101 recovered cases from 493 districts across all 34 provinces1.

• WHO is supporting the Ministry of Health (MoH) in a seroepidemiological study for 17 selected provinces across Indonesia (pages 14-16).

• WHO continues to facilitate the comprehensive field assessment in 15 provinces to strengthen national COVID-19 response (page 18).

Figure 1: Geographic distribution of cumulative number of confirmed COVID-19 cases in Indonesia across the provinces reported between 10 to 16 September 2020. Source of data

Disclaimer: The number of cases reported daily is not equivalent to the number of persons who contracted COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week from the time of testing.

1 https://infeksiemerging.kemkes.go.id/ 1 WHO Indonesia Situation Report - 25 who.int/indonesia

GENERAL UPDATES

• On 14 September, Jakarta reimposed large-scale social restrictions (PSBB) for a period of two weeks. The former PSBB was relaxed to enter a transitional PSBB in early June. Governor Anies Baswedan announced that schools, tourist locations, recreational areas, public parks, sporting facilities, weddings, seminars and conferences will be closed or suspended for two weeks. Traditional markets and shopping malls will only be allowed to operate at 50% capacity, and restaurants and cafes will only be allowed to provide deliveries. In contrast to the former PSBB, enacted in April, places of worship in residential areas and housing complexes will remain open at 50% capacity, though in red zones, larger houses of worship will be closed. Public transportation will be limited to 50% of passenger capacity and the odd-even license plate traffic policy will be suspended for the duration of PSBB2. In anticipation of citizens of Jakarta travelling to Bogor to avoid PSBB, the mayor of Bogor is preparing to intensify emphasis on health protocols or physical restrictions in areas that might be destinations for people coming from Jakarta3. Bogor will implement micro-scale social restrictions (PSBM) until 28 September, which will focus on strengthening monitoring at neighbourhood units and community units (RT and RW)4.

• The Province Health Office (PHO) of Jakarta issued circular no. 399/2020 on 04 September, stating 13 hospitals to be solely designated for COVID- 19-related services. These hospitals will provide COVID-19 services in all hospital service areas; transfer non-COVID-19 patients (in- and outpatient) to other hospitals that provide services for non-COVID-19 patients; conduct quality management, patient care and specimen referral of COVID-19 according to the set standards; implement service flow, room arrangement, and implementation of infection prevention and control (IPC) in all hospital areas according to COVID-19 referral hospital directives; improve human resource capacity, infrastructure, and availability of medical and personal protective equipment (PPE) and other consumables; and carry out recording and reporting according to the regulation.

2 https://www.thejakartapost.com/news/2020/09/13/jakarta-will-resume-full-psbb-on-monday-anies- confirms.html?src=mostviewed&pg=news/2020/09/13/central-government-supports-return-to-full-psbb-anies- says.html 3 https://en.tempo.co/read/1385920/bogor-mayor-responds-to-jakartas-reimposed-psbb-social-restriction 4 https://en.tempo.co/read/1386365/bogor-mayor-extends-micro-scale-social-restriction-to-curb-covid-19-cases 2 WHO Indonesia Situation Report - 25 who.int/indonesia

SURVEILLANCE

• On 16 September, 3 963 new and 228 993 cumulative confirmed COVID-19 cases were reported nationwide (Fig. 2). The average for the last seven days was 3 664 cases per day, compared to 3 242 per day for the previous seven days. 4500 250000

4000

3500 200000

3000 150000 2500

2000

100000 Daily numberDaily

1500 Cumulative number Cumulative

1000 50000 500

0 0

6-Jul

1-Jun 8-Jun

6-Apr

7-Sep

3-Aug

13-Jul 20-Jul 27-Jul

2-Mar 9-Mar

4-May

15-Jun 22-Jun 29-Jun

13-Apr 20-Apr 27-Apr

14-Sep

10-Aug 17-Aug 24-Aug 31-Aug

16-Mar 23-Mar 30-Mar

11-May 18-May 25-May Daily number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 2: Daily and cumulative number of cases reported in Indonesia, as of 16 September 2020. Source of data

Disclaimer: The number of cases reported daily is not the number of persons who contracted COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week from the time of testing. Therefore, caution must be taken in interpreting this figure and the epidemiological curve for further analysis.

• As of 16 September, 59.4% of confirmed cases were in Java: DKI Jakarta, East Java, Central Java and West Java are the four top provinces in terms of number of confirmed cases. South Sulawesi is the only province outside Java that is among the top five provinces in terms of number of confirmed cases. The cumulative number of confirmed COVID-19 cases by province is shown in Figure 3.

3 WHO Indonesia Situation Report - 25 who.int/indonesia

DKI Jakarta East Java Central Java West Java South Sulawesi South Kalimantan North Sumatra Bali East Kalimantan South Sumatra Papua Riau North Sulawesi Banten West Sumatra Aceh Central Kalimantan West Nusa Tenggara Province Maluku Gorontalo Southeast Sulawesi North Maluku Yogyakarta Riau Islands West Papua West Kalimantan Lampung North Kalimantan Bengkulu West Sulawesi Jambi Bangka Belitung Islands East Nusa Tenggara Central Sulawesi

0 10000 20000 30000 40000 50000 60000 70000 Cumulative number of confirmed COVID-19 cases

Figure 3: Cumulative number of confirmed COVID-19 cases by province in Indonesia, as of 16 September 2020. Source of data

Disclaimer: Data from DKI Jakarta include patients isolated or hospitalized in Wisma Atlet (RSDC: Rumah Sakit Darurat COVID-19), which is the biggest national makeshift hospital for COVID-19; some patients may not be residents of DKI Jakarta. The same may apply to other provinces.

4 WHO Indonesia Situation Report - 25 who.int/indonesia

• As of 16 September, DKI Jakarta had the highest confirmed COVID-19 mortality per one million population, followed by South Kalimantan, East Java, East Kalimantan, North Sulawesi, and North Maluku (Fig. 4).

DKI Jakarta South Kalimantan East Java East Kalimantan North Sulawesi North Maluku Gorontalo Central Kalimantan South Sulawesi Bali South Sumatra West Nusa Tenggara Central Java North Sumatra West Papua Riau Islands Aceh Maluku Province Papua Southeast Sulawesi West Sumatra Bengkulu Yogyakarta Riau Banten West Java West Sulawesi North Kalimantan Central Sulawesi Lampung Bangka Belitung Islands Jambi West Kalimantan East Nusa Tenggara 0 20 40 60 80 100 120 140 160 Death per one million population

Figure 4: Cumulative deaths per one million population by province in Indonesia, as of 16 September 2020. Source of data

Disclaimer: Based on data availability, only confirmed COVID-19 deaths have been included; however, as per the WHO definition, death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause of death that cannot be related to COVID-19 (e.g. trauma). There should be no period of complete recovery between the illness and death. 5 WHO Indonesia Situation Report - 25 who.int/indonesia

• As of 16 September, the daily numbers of specimens and people tested were 39 774 and 30 713, respectively. As of the same day, the daily number of suspected cases was 100 236 (Fig. 5). The weekly average numbers of specimens and people tested in the last seven days were 34 344 and 24 734, respectively.

120000

100000

80000

60000 Number

40000

20000

3-Jul 7-Jul

1-Jun 5-Jun 9-Jun

5-Sep 1-Sep 9-Sep

4-Aug 8-Aug

11-Jul 15-Jul 19-Jul 23-Jul 27-Jul 31-Jul

25-Jun 13-Jun 17-Jun 21-Jun 29-Jun

13-Sep

12-Aug 16-Aug 20-Aug 24-Aug 28-Aug Number of specimens tested Number of people tested Number of suspected cases

Figure 5: The daily number of specimens, suspected COVID-19 cases, and people tested in Indonesia, from 01 June to 16 September 2020. Source of data

Disclaimer: Due to the transition to a new data management application, there may have been reporting issues in timing. Therefore, on certain days the number of specimens tested is almost the same as the number of suspected cases tested, which might not have been the situation.

6 WHO Indonesia Situation Report - 25 who.int/indonesia

EPIDEMIOLOGICAL CRITERIA TO ASSESS COVID-19 TRANSMISSION

Table 1: Assessment of epidemiological criteria for six provinces in Java for the 3-week period from 24 August to 13 September 2020. Province Decline in the number of Decrease in the confirmed COVID-19 cases number of since the latest peak* confirmed and probable case deaths for the last 3 weeks**

DKI Jakarta Latest peak last week No West Java Latest peak last week No Central Java Latest peak last week No Yogyakarta Latest peak last week No East Java Latest peak last week No Banten Latest peak last week No

*date of latest peak differs for each province (see Figs. 6 to 11 for details) **decrease in deaths is calculated from 24 August to 13 September 2020 (see Fig. 13 for details)

Criterion 1: Decline of at least 50% over a 3-week period since the latest peak and continuous decline in the observed incidence of confirmed and probable cases

• The latest peak in the number of confirmed COVID-19 cases for all provinces in Java occurred last week (Figs. 6 to 11).

7 WHO Indonesia Situation Report - 25 who.int/indonesia

9000 DKI Jakarta 60000 8000 50000 7000 6000 40000 5000 30000 4000

3000 20000 Weekly number Weekly

2000 number Cumulative 10000 1000

0 0

16/03 - 22/03 - 16/03 10/05 - 04/05 02/03 - 08/03 -02/03 15/03 -09/03 29/03 -23/03 05/04 -30/03 12/04 -06/04 19/04 -13/04 26/04 -20/04 03/05 -27/04 17/05 -11/05 24/05 -18/05 31/05 -25/05 07/06 -01/06 14/06 -08/06 21/06 -15/06 28/06 -22/06 05/07 -29/06 12/07 -06/07 19/07 -13/07 26/07 -20/07 02/08 -27/07 09/08 -03/08 16/08 -10/08 23/08 -17/08 30/08 -24/08 06/09 -31/08 13/09 -07/09 Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 6: Weekly and cumulative number of confirmed COVID-19 cases in DKI Jakarta, as of 13 September 2020. Source of data

2000 West Java 16000 1800 14000 1600 12000 1400 1200 10000 1000 8000 800 6000 600 Weekly number Weekly 4000

400 number Cumulative 200 2000

0 0

Figure 7: Weekly and cumulative number of confirmed COVID-19 cases in West Java, as of 13 September 2020. Source of data 8 WHO Indonesia Situation Report - 25 who.int/indonesia

3000 Central Java 20000 18000 2500 16000 2000 14000 12000 1500 10000 8000

1000 6000 Weekly number Weekly

500 4000 number Cumulative 2000

0 0

23/03 - 29/03 - 23/03 17/05 - 11/05 02/03 - 08/03 -02/03 15/03 -09/03 22/03 -16/03 05/04 -30/03 12/04 -06/04 19/04 -13/04 26/04 -20/04 03/05 -27/04 10/05 -04/05 24/05 -18/05 31/05 -25/05 07/06 -01/06 14/06 -08/06 21/06 -15/06 28/06 -22/06 05/07 -29/06 12/07 -06/07 19/07 -13/07 26/07 -20/07 02/08 -27/07 09/08 -03/08 16/08 -10/08 23/08 -17/08 30/08 -24/08 06/09 -31/08 13/09 -07/09 Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 8: Weekly and cumulative number of confirmed COVID-19 cases in Central Java, as of 13 September 2020. Source of data

300 Yogyakarta 2000 1800 250 1600 200 1400 1200 150 1000 800

100 600 Weekly number Weekly

50 400 number Cumulative 200

0 0

13/04 - 19/04 - 13/04 10/05 - 04/05 31/05 - 25/05 02/03 - 08/03 -02/03 15/03 -09/03 22/03 -16/03 29/03 -23/03 05/04 -30/03 12/04 -06/04 26/04 -20/04 03/05 -27/04 17/05 -11/05 24/05 -18/05 07/06 -01/06 14/06 -08/06 21/06 -15/06 28/06 -22/06 05/07 -29/06 12/07 -06/07 19/07 -13/07 26/07 -20/07 02/08 -27/07 09/08 -03/08 16/08 -10/08 23/08 -17/08 30/08 -24/08 06/09 -31/08 13/09 -07/09 Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 9: Weekly and cumulative number of confirmed COVID-19 cases in Yogyakarta, as of 13 September 2020. Source of data 9 WHO Indonesia Situation Report - 25 who.int/indonesia

3500 East Java 40000 3000 35000 2500 30000 25000 2000 20000 1500 15000

Weekly number Weekly 1000 10000 Cumulative number Cumulative 500 5000

0 0

30/03 - 05/04 - 30/03 24/05 - 18/05 12/07 - 06/07 02/03 - 08/03 -02/03 15/03 -09/03 22/03 -16/03 29/03 -23/03 12/04 -06/04 19/04 -13/04 26/04 -20/04 03/05 -27/04 10/05 -04/05 17/05 -11/05 31/05 -25/05 07/06 -01/06 14/06 -08/06 21/06 -15/06 28/06 -22/06 05/07 -29/06 19/07 -13/07 26/07 -20/07 02/08 -27/07 09/08 -03/08 16/08 -10/08 23/08 -17/08 30/08 -24/08 06/09 -31/08 13/09 -07/09 Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 10: Weekly and cumulative number of confirmed COVID-19 cases in East Java, as of 13 September 2020. Source of data

350 Banten 4000 300 3500 250 3000 2500 200 2000 150 1500

Weekly number Weekly 100 1000 Cumulative number Cumulative 50 500

0 0

02/03 - 08/03 -02/03 15/03 -09/03 22/03 -16/03 29/03 -23/03 05/04 -30/03 12/04 -06/04 19/04 -13/04 26/04 -20/04 03/05 -27/04 10/05 -04/05 17/05 -11/05 24/05 -18/05 31/05 -25/05 07/06 -01/06 14/06 -08/06 21/06 -15/06 28/06 -22/06 05/07 -29/06 12/07 -06/07 19/07 -13/07 26/07 -20/07 02/08 -27/07 09/08 -03/08 16/08 -10/08 23/08 -17/08 30/08 -24/08 06/09 -31/08 13/09 -07/09 Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 11: Weekly and cumulative number of confirmed COVID-19 cases in Banten, as of 13 September 2020. Source of data 10 WHO Indonesia Situation Report - 25 who.int/indonesia

Criterion 2: Less than 5% of samples positive for COVID-19, at least for the last 2 weeks, assuming that surveillance for suspected cases is comprehensive

• The percentage of positive samples can be interpreted only with comprehensive surveillance and testing, in the order of one per 1 000 population per week. DKI Jakarta and West Sumatra have achieved this minimum case detection benchmark for the last three weeks; West Papua met this benchmark last week (Fig. 12). 6.00 50.0%

5.50 45.0% 5.00 40.0% 4.50 35.0% 4.00 3.50 30.0% 3.00 25.0%

2.50 20.0% Positivity rate Positivity 2.00 15.0% 1.50 Benchmark: One case tested 10.0% 1.00 per 1000 population per week Threshold positivity rate <5% 5.0%

Suspected cases tested/1000 population/week tested/1000 cases Suspected 0.50 - 0.0% 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 Indonesia Yogyakarta DKI Jakarta West Sumatra South Central West Sumatra Kalimantan Papua Weeks People tested/1000 population/week Positivity rate

Figure 12: Positivity rate of samples, and people tested per 1 000 population per week: Week 1: 24/08/20 - 30/08/20; Week 2: 31/08/20 - 06/09/20; Week 3: 07/09/20 - 13/09/20

For surveillance purposes, positivity rate is calculated as the number of confirmed cases divided by the number of people tested for diagnosis. Source of data: Indonesia, Yogyakarta, DKI Jakarta, West Sumatra, South Sumatra, Central Kalimantan, West Papua

Note: Due to a limitation in data, other provinces could not be evaluated.

11 WHO Indonesia Situation Report - 25 who.int/indonesia

Criterion 3: Decline in the number of deaths among confirmed and probable cases for the last 3 weeks

DKI Jakarta West Java 500 50 400 40 300 311 30 27 21 270 200 203 20 100 10 15 79 103 121 16 18 0 0 6 24/08/20 - 31/08/20 - 07/09/20 - 24/08/20 - 31/08/20 - 07/09/20 - 30/08/20 06/09/20 13/09/20 30/08/20 06/09/20 13/09/20 Other death with COVID-19 protocol Death-Confirmed-Case Death-Probable-Case Death-Confirmed-Case

Central Java Yogyakarta 200 10 150 8 6 100 163 4 9 131 112 50 2 4 4 0 0 24/08/20 - 31/08/20 - 07/09/20 - 24/08/20 - 31/08/20 - 07/09/20 - 30/08/20 06/09/20 13/09/20 30/08/20 06/09/20 13/09/20 Death-Confirmed-Case Death-Confirmed-Case East Java Banten 250 25 26 33 200 54 20 8 150 15 100 196 218 10 2 177 15 50 5 9 1 5 0 0 24/08/20 - 31/08/20 - 07/09/20 - 24/08/20 - 31/08/20 - 07/09/20 - 30/08/20 06/09/20 13/09/20 30/08/20 06/09/20 13/09/20 Death-Confirmed-Case Death-Probable-Case Death-Confirmed-Case Death-Probable-Case

12 WHO Indonesia Situation Report - 25 who.int/indonesia

Figure 13: Deaths among confirmed COVID-19 cases, patients under investigation (PDP) and persons under observation (ODP) per week over the last three weeks from 24 August to 13 September 2020 in six provinces in Java. Source of data: DKI Jakarta, West Java, Central Java, East Java, Yogyakarta, Banten

Disclaimer: The data are provisional. Central Java has started to use updated case definitions as of last week. There may be a discrepancy in the number of deaths of confirmed COVID-19 cases between national and provincial data sources.

• From 10 to 11 September, WHO and partners, in collaboration with MoH and the COVID-19 Task Force (Satuan Tugas (Satgas)), conducted a refresher training on contact tracing for all 514 districts in Indonesia. Close to 700 participants attended the webinar which was divided into four sessions. In one session, participants from the subnational levels shared their experience in contact tracing with DKI Jakarta, North Sulawesi, South Sulawesi, West Kalimantan, West Sumatra and other provinces also discussing lessons learned (Fig. 14). The Director General of Communicable Disease Control and Prevention, MoH, launched a handbook on contact tracing to be used by field contact tracers to enhance surveillance nationwide.

Figure 14: Provinces sharing lessons learned on contact tracing during a webinar, 11 September 2020. 13 WHO Indonesia Situation Report - 25 who.int/indonesia

HEALTH SYSTEM CRITERIA TO ASSESS COVID-19 TRANSMISSION

• The number of confirmed COVID-19 cases hospitalized in DKI Jakarta since the beginning of June had gradually decreased until 07 July; however, since 08 July, the number has been progressively increasing (Fig. 15). 5000 4500

4000

19 cases cases 19 - 3500 3000 2500 2000 hospitalized 1500 1000 500

Number of confirmed COVID ofNumberconfirmed 0

7-Jul 1-Jul 4-Jul

1-Jun 4-Jun 7-Jun

2-Sep 5-Sep 8-Sep

3-Aug 6-Aug 9-Aug

10-Jul 13-Jul 16-Jul 19-Jul 22-Jul 25-Jul 28-Jul 31-Jul

10-Jun 13-Jun 16-Jun 19-Jun 22-Jun 25-Jun 28-Jun

11-Sep

15-Aug 12-Aug 18-Aug 21-Aug 24-Aug 27-Aug 30-Aug Figure 15: Number of confirmed COVID-19 cases hospitalized in DKI Jakarta from 01 June to 13 September 2020. Source of data

Disclaimer: Data from Wisma Atlet are not included.

SEROEPIDEMIOLOGICAL STUDY

• Indonesia is participating in a population-based age-stratified seroepidemiological study coordinated by WHO. The study aims to measure the prevalence of antibodies to SARS-CoV-2 and the fraction of asymptomatic, pre-symptomatic, or subclinical people in the general population by sex and age group to identify the scope of the disease in a community. This was announced through a media release in English and Indonesian on 02 July. This study is part of the WHO Unity Study, a global initiative to enable countries, in various resource settings, to rapidly gather robust data on key epidemiological parameters to better understand, respond to and control the COVID-19 pandemic. 14 WHO Indonesia Situation Report - 25 who.int/indonesia

• In Indonesia, the study will be implemented with a cross-sectional approach and one-time data collection. Serum specimens will be taken from 10 200 participants and examined with an immunological assay called the enzyme- linked immunosorbent assay (ELISA) test to detect and measure the presence of antibodies against SARS-CoV-2. Sixty-nine districts in 17 provinces have been randomly selected with the Probability Proportional to Size (PPS)-method based on the individual size, population and incidence of infection in each of these provinces (Fig.16). Risk factors, symptoms, and knowledge, attitude, and practice (KAP) study data will also be collected using questionnaires. The results will be analyzed to estimate the seroprevalence, proportion of asymptomatic cases and risk factors in the general population. The study will involve multidisciplinary researchers from various academic and research institutions along with experts in acute respiratory infection, regional referral laboratories and health authorities at the subnational level.

Figure 16: Distribution of seroepidemiological study sites in Indonesia, September 2020. Source: Population-based age-stratified seroepidemiological investigation protocol for COVID-19 infection in Indonesia 15 WHO Indonesia Situation Report - 25 who.int/indonesia

• WHO has been supporting MoH to develop the study protocol, as well as logistics and resource mobilization for the study. Some activities from September are highlighted below:

i. On 11 September, WHO provided MoH with 127 kits of reagents that can perform up to 12 192 antibody tests (Fig. 17).

Figure 17: WHO handed over reagents to the MoH to perform antibody tests for the seroepidemiological study in Indonesia, September 2020. Credit: The National Institute of Health Research and Development.

ii. On 08 September, WHO supported the first virtual orientation for the 17 provinces in collaboration with MoH (Fig. 18). WHO presented the sample collection, logistics distribution and laboratory requirements of testing for the study. The National Institute of Health Research and Development (NIHRD) has been appointed as the National Reference Laboratory for quality assurance of the study and eight subnational laboratories have been appointed as testing laboratories. Training for field officers in 69 selected districts and field testing in DKI Jakarta will be conducted before specimen collection starts in October.

16 WHO Indonesia Situation Report - 25 who.int/indonesia

HEALTH OPERATIONS

• As reported by the government on 16 September, the number of people tested for COVID-19 with polymerase chain reaction (PCR) was 30 713 and the cumulative number of people tested was 1 622 769 (Fig. 18). As of the same day, the proportion of people that had recovered among the total confirmed COVID-19 cases was 71.7% (Fig. 19) and there were 55 792 confirmed COVID-19 cases under care or in isolation5.

35000 2000000 30000 25000 1500000 20000 1000000 15000 10000

Daily numberDaily 500000 5000

0 0 number Cumulative

4-Jul

6-Jun

4-Apr

5-Sep

1-Aug 8-Aug

11-Jul 18-Jul 25-Jul

7-Mar

2-May 9-May

13-Jun 20-Jun 27-Jun

11-Apr 18-Apr 25-Apr

12-Sep

15-Aug 22-Aug 29-Aug

14-Mar 21-Mar 28-Mar

16-May 23-May 30-May Reporting date

Daily number of people tested with PCR Cumulative number of people tested with PCR

Figure 18: Daily and cumulative number of suspected COVID-19 cases tested with polymerase chain reaction (PCR) in Indonesia, as of 16 September 2020. Source of data

200000 80.0 70.0 150000 60.0 50.0 100000 40.0 30.0 50000 20.0 10.0 (%) Percentage

Cummulative number Cummulative 0 0.0

6-Jul

6-Jun

1-Apr 7-Apr

4-Sep

5-Aug

12-Jul 18-Jul 24-Jul 30-Jul

1-May 7-May

12-Jun 18-Jun 24-Jun 30-Jun

13-Apr 19-Apr 25-Apr

10-Sep 16-Sep

29-Aug 11-Aug 17-Aug 23-Aug

19-May 13-May 25-May 31-May Cumulative number of recovered cases Percentage recovery

Figure 19: Cumulative number of recovered cases and percentage recovery from COVID-19 in Indonesia, as of 16 September 2020. Source of data

5 https://covid19.go.id/ 17 WHO Indonesia Situation Report - 25 who.int/indonesia

• On 16 and 17 September, MoH, with support from WHO, will conduct a webinar on IPC for hospitals in the eastern region of the country. This is the last in the webinar series which was a recommendation from the COVID-19 exposure risk assessment of healthcare workers. On 02 and 08 September, the virtual training was conducted for the western and central regions, with 300 registered participants in attendance and over 2 000 participants joining through YouTube.

PLANNING, RISK AND NEEDS ASSESSMENT • WHO continues to support MoH with the comprehensive field assessment in 15 provinces. The enumerators are collecting, compiling and analyzing the data obtained through checklists from PHOs, District Health Offices (DHOs), provincial laboratories, hospitals, port health posts, the COVID-19 Task Force, puskesmas and community health posts (posyandu) (Fig. 20). Most of these enumerators are volunteers selected by the Satgas. The assessment is expected to be finalized by the end of September. The results will be used to identify strengths, best practices, gaps and challenges of the COVID-19 response; they will also guide the development of recommendations and the update of COVID-19 response plans at the provincial and national-level, which will complement the Intra-Action Review (IAR).

Figure 20: Volunteers conducting a field assessment interview in a District Health Office in Bali, September 2020. Credit: WHO 18 WHO Indonesia Situation Report - 25 who.int/indonesia

• From 10 to 11 September, WHO facilitated a video conference for the review of the COVID-19 operational response plans based on the IAR recommendations. The stakeholders presented proposed activities, indicators and budgets for the revised response plans. While all provinces are updating their plans, North Sulawesi is finalizing its plan and Yogyakarta presented its draft on 15 September.

• On 16 September, WHO and MoH will share the experience and benefits of conducting an IAR in a WHO South-East Asia Regional Office webinar. MoH Indonesia will present its experience with the aim of encouraging other countries in the region to conduct an IAR.

RISK COMMUNICATION • WHO advised the public communication section of the COVID-19 Mitigation and National Economic Recovery Team (Komite Penanganan COVID-19 dan Pemulihan Ekonomi Nasional or KPCPEN) to develop information, education and communication (IEC) messages for the community to reiterate health protocols during COVID-19 in alignment with important health commemoration days, holidays and observances. Subsequently, KPCPEN published IEC materials for the National Sports Day on 09 September and for the National Oral and Dental Health Day on 12 September.

• WHO is regularly translating and sharing important health messages on the website and social media platforms – Twitter and Instagram – and has recently published:

- Questions and answers on children and masks

- Advice on the use of masks for children in the community in the context of COVID-19

- Infographics on: ▪ Addressing domestic violence ▪ COVID-19 and NCDs ▪ Guidance for organizing small gatherings (Fig. 21)

19 WHO Indonesia Situation Report - 25 who.int/indonesia

Figure 21: Infographics from the 'COVID-19 and NCDs' series, September 2020.

CONTINUITY OF ESSENTIAL HEALTH SERVICES

• WHO is supporting the government for programme analysis of various essential health services to ensure their continuity during the pandemic. Highlights of the initial malaria programme analysis can be found in WHO Situation Report 15. Updates from the programme are presented below:

i. There continues to be a decline in active and passive case finding as well as reported malaria cases from April to July 2020, compared to the same period in 2019 (Fig. 22). The figures from January to June were presented in WHO Situation Report 15.

ii. Community case finding in Papua was suspended by the local government from March to August 2020; however, some village malaria workers/Juru Malaria Desa (VMWs/JMD) still conducted malaria testing using rapid diagnostic tests (RDT) at home by setting up hand washing stations in front of their houses and using gloves and fabric masks. As of September, community case finding resumed in Papua. Persatuan Karya Dharma Kesehatan Indonesia (PERDHAKI), a community-based organization and one of the Principal Recipients of the Global Fund grant in Indonesia, has distributed PPE for VMWs/JMD 20 WHO Indonesia Situation Report - 25 who.int/indonesia

250000 30000

200000 25000 20000 150000 15000 100000

Number of case finding ofcase Number 10000 50000 5000 cases ofconfirmed Number

0 0 Apr May Jun Jul Case Finding 2019 223221 214012 183657 213387 Case Finding 2020 91267 76847 87035 67568 Confirmed case 2019 21996 25089 22266 23621 Confirmed case 2020 13165 12246 8997 10945 Figure 22: Trend of malaria case finding and confirmed malaria cases reported from April to July 2019 vs April to July 2020. Source: SISMAL database accessed on 21 August 2020, data reported from 34 provinces.

iii. Advocacy: WHO was an event partner of Malaria Week 2020, hosted virtually by the Asia Pacific Leaders Malaria Alliance (APLMA), Asia Pacific Malaria Elimination Network (APMEN) and the National Institute of Malariology, Parasitology and Entomology (NIMPE), Ministry of Health, Viet Nam, from 07 to 11 September. WHO contributed to chairing the breakout session on ‘Strong Surveillance Systems and Timely Reporting’ in which multi-country and multi-sector participants reflected on the importance of supporting malaria elimination through robust surveillance systems and real-time data during the COVID-19 pandemic.

iv. Guidance: MoH is revising some of its recommendations to adjust them to the pandemic situation. WHO reviewed the draft of the MoH guidance on malaria elimination certification and provided input to ensure that the procedure of certification is consistent with the WHO framework for malaria elimination. Other activity protocols have also been revised in line with WHO guidance on ‘Maintaining essential health services: operational guidance for the COVID-19 context’. As an example, the guideline on long-lasting insecticidal net (LLIN) distribution has been adjusted by simplifying the reporting.

21 WHO Indonesia Situation Report - 25 who.int/indonesia v. Surveillance: To enhance case finding, some health facilities in Papua have started screening all suspected COVID-19 cases for malaria. As a result, co-infection of malaria and COVID-19 has been observed. One hospital in Jayapura district reported that approximately 10% of COVID- 19 cases were co-infected with malaria.

vi. Human resources: WHO is supporting the National Malaria Control Program (NMCP), other sub-directorates and partners to conduct virtual capacity building during the pandemic. A series of ten webinars on vector and animal reservoir control and surveillance is being conducted from 13 June to 31 October. The second Annual Malaria Research in Indonesia (AMRI) took place from 25 June to 27 August. These ten webinars were aimed to bridge communications between the malaria programme and researchers on diagnosis, treatment, epidemiology, vector biology and control, surveillance, innovation and future research on malaria in Indonesia with focus on reaching elimination by 2030.

vii. Prevention: All targeted areas for LLINs in 2020 have received LLINs and some districts have distributed them to the community. WHO is supporting the NMCP in monitoring durability and efficacy of LLINs in Papua, in line with WHO guidelines. The field data collection was rescheduled from once every six months to one time only in 2020 due to PSBB, and took place from August to September. Results will inform LLIN distribution and replacement schedules, behaviour and communication messages, and procurement.

viii. Outbreak response: WHO supported the NMCP in tackling a malaria outbreak in Rokan Hilir District, Riau Province. The outbreak began in October 2019 with an initial successful response and reduction in cases; however, a substantial increase in cases was observed due to implementation of PSBB and reduced capacity of the health system during the pandemic. WHO is supporting the assessment of the outbreak and is providing technical knowledge to local health workers, ensuring that local authorities can manage the malaria outbreak, even during the pandemic.

22 WHO Indonesia Situation Report - 25 who.int/indonesia PARTNER COORDINATION

• On 10 September, WHO participated in a meeting convened by the Coordinating Ministry of Human Development and Culture alongside other partners and ministries to discuss the COVID-19 vaccine candidates and an introduction and deployment plan whenever the vaccine becomes available. The COVAX Facility will supply participating countries with vaccine doses to immunize 20% of the country’s population. It will initially provide vaccines for 3% of the total population which will cover health workers and essential staff, followed by another 17% for priority population groups, in 2021. The government is also in bilateral negotiations with manufacturers for securing additional doses of vaccines. The government’s major focus remains the production of a local vaccine.

• Overall funding request for WHO operations and technical assistance is US$ 46 million (27 million for response and 19 million for recovery phase), based on estimated needs as of September 2020 (Fig. 23).

Figure 23: WHO funding situation for COVID-19 response, September 2020

Data presented in this situation report have been taken from publicly available data from the MoH (https://infeksiemerging.kemkes.go.id/), BNPB (http://covid19.go.id) and provincial websites. There may be differences in national and provincial data depending on the source used. All data are provisional and subject to change.

23 WHO Indonesia Situation Report - 25 who.int/indonesia A SNAPSHOT OF WHO COURSES AND INFORMATION MATERIAL

Online WHO COVID-19 courses: • Operational planning guidelines and COVID-19 • Clinical management of severe acute respiratory infections • Health and safety briefing for respiratory diseases – eProtect • Infection prevention and control • Emerging respiratory viruses, including COVID-19 • Design of severe acute respiratory infection treatment facility

WHO guidance: • Doing things that matter • Considerations for school-related public health measures • Cleaning and disinfection of environmental surfaces • Guiding principles for immunization activities during the COVID-19 pandemic • Maintaining a safe and adequate blood supply during the COVID-19 pandemic

Infographics: • COVID-19 and disabilities • Attending small gatherings • Organizing small gatherings • Staying safe during COVID-19 • Staying healthy in workplace • Substance abuse • Feeding young children • Take care in your workplace • Safe travel during COVID-19

Questions and answers: • Ventilation and air conditioning in the context of COVID-19 • Ventilation and air conditioning in health facilities • Ventilation and air conditioning in public spaces • COVID-19 transmission • Contact tracing

Videos: • Immunization during COVID-19 • Stay healthy at home • How to protect yourself from COVID-19 • Take care in your workplace • Safe travel during COVID-19

For more information please feel free to contact: [email protected] WHO Indonesia Reports 24 WHO Indonesia Situation Report - 25 who.int/indonesia